|
No. of cases |
median dosage |
median treatment
duration |
Group B |
|
|
|
LEF |
5 |
15mg daily |
8 years |
MTX |
9 |
12.5mg weekly |
10 years |
TGP |
1 |
1200mg daily |
0.5 years |
TG |
7 |
40mg daily |
14 years |
SASP |
1 |
2000mg daily |
5 years |
ETN |
2 |
25mg biweekly |
0.5 years |
Group C |
|
|
|
DMARDs |
|
|
|
IGU |
2 |
50mg daily |
1 years |
MTX |
18 |
12.5mg weekly |
12 years |
PA |
1 |
1000mg daily |
6 years |
TG |
13 |
60mg daily |
8 years |
SASP |
1 |
2000mg daily |
4 years |
ETN |
3 |
25mg biweekly |
0.5 years |
GC |
|
|
|
PRDL |
4 |
7.5mg daily |
11.5 years |
PRED |
16 |
10mg daily |
12 years |
MPS |
1 |
8mg bi-daily |
21 years |